In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sun Pharmaceutical Industries Ltd.

https://www.sunpharma.com/

Latest From Sun Pharmaceutical Industries Ltd.

MSD Licenses Molnupiravir In India

MSD India outlines further specifics around the just-announced voluntary licensing deal for molnupiravir with Indian firms, noting an expectation to discuss local data needs with the country’s regulator. All eyes are also on whether non-licensee Natco will stay the course for its application for the investigational antiviral.

Deals Coronavirus COVID-19

Molnupiravir India Licenses: Nuances, Local Data In Focus

MSD-India Region chief outlines further specifics around the just-announced voluntary licensing deal for molnupiravir with Indian firms, noting an expectation to discuss local data needs with the country’s regulator. All eyes are also on whether non-licensee Natco will stay the course for its application for the investigational antiviral.

India Commercial

Natco Tests Compassionate Use Window In India For Merck’s COVID Pill

Natco seeks emergency approval in India for investigational therapy molnupiravir, currently being developed by Merck & Co for the treatment of non-hospitalized COVID-19 patients. The firm has linked its request to compassionate use amid a ferocious surge in COVID-19 cases in India, posing a potentially delicate choice for the regulator.

Research & Development Coronavirus COVID-19

Sun Pharma US Business Co-packages OTC Emergency Contraceptive With Pregnancy Test

My After Plan has been available online and in stores since October 2020, shortly before Sun Pharma received registration for the trademark in the US. Recently, marketing and design consultants announced their work for Sun Pharma's Ohm Labs on My After Plan packaging.

Advertising, Marketing & Sales OTC Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Aditya Acquisition Company ltd
    • Caraco Pharmaceutical Laboratories, Ltd.
    • DUSA Pharmaceuticals, Inc.
    • InSite Vision, Inc.
    • JSC Biosintez
    • Ocular Technologies
    • Pola Pharma Inc.
    • Ranbaxy Laboratories Limited
    • Ranbaxy Solus
    • Solus Care
    • Sun Ophthalmics
    • Sun Pharma Global FZE
UsernamePublicRestriction

Register